Published in Ophthalmology on October 01, 2002
Incidence of endophthalmitis in a large series of 23-gauge and 20-gauge transconjunctival pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2009) 1.73
25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol (2006) 1.70
Sutureless vitrectomy. Indian J Ophthalmol (2008) 1.66
Iatrogenic retinal breaks in 20-G versus 23-G pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2013) 1.59
Expanded indications for 25-gauge transconjunctival vitrectomy. Jpn J Ophthalmol (2005) 1.57
25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol (2007) 1.47
Primary 25-gauge transconjunctival sutureless vitrectomy in pseudophakic retinal detachment. Indian J Ophthalmol (2007) 1.44
Transition to a novel advanced integrated vitrectomy platform: comparison of the surgical impact of moving from the Accurus vitrectomy platform to the Constellation Vision System for microincisional vitrectomy surgery. Clin Ophthalmol (2013) 1.39
Microincision cataract surgery combined with vitrectomy: a case series. Eye (Lond) (2014) 1.29
The safety and efficacy of transconjunctival sutureless 23-gauge vitrectomy. Korean J Ophthalmol (2007) 1.16
Performance analysis of new-generation vitreous cutters. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases. Graefes Arch Clin Exp Ophthalmol (2011) 1.13
Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection. Indian J Ophthalmol (2009) 1.11
Surgically induced astigmatism in combined phacoemulsification and vitrectomy; 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge standard vitrectomy. Graefes Arch Clin Exp Ophthalmol (2009) 1.06
Changes in day 1 post-operative intraocular pressure following sutureless 23-gauge and conventional 20-gauge pars plana vitrectomy. Open Ophthalmol J (2013) 1.00
Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment. Graefes Arch Clin Exp Ophthalmol (2016) 0.98
Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion. Graefes Arch Clin Exp Ophthalmol (2016) 0.95
Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2010) 0.95
The incidence and distribution of iatrogenic retinal tears in 20-gauge and 23-gauge vitrectomy. Eye (Lond) (2011) 0.94
Adverse events after pars plana vitrectomy among medicare beneficiaries. Arch Ophthalmol (2009) 0.94
Retinal detachment after small-incision, sutureless pars plana vitrectomy: possible causative agents. Graefes Arch Clin Exp Ophthalmol (2010) 0.93
Comparison of postoperative intraocular pressure changes between 23-gauge transconjunctival sutureless vitrectomy and conventional 20-gauge vitrectomy. Eye (Lond) (2012) 0.92
25-gauge microincision vitrectomy to treat vitreoretinal disease in glaucomatous eyes after trabeculectomy. J Ophthalmol (2014) 0.91
Acute endophthalmitis after 25-gauge sutureless vitrectomy. Int Ophthalmol (2007) 0.91
Successful removal of large intraocular foreign body by 25-gauge microincision vitrectomy surgery. J Ophthalmol (2011) 0.90
Sutureless 25-gauge vitrectomy for idiopathic macular hole repair. Graefes Arch Clin Exp Ophthalmol (2007) 0.90
Passive removal of silicone oil with a 25-gauge sutureless system. Jpn J Ophthalmol (2008) 0.89
Modified incision in 25-gauge vitrectomy in the creation of a tunneled airtight sclerotomy: an ultrabiomicroscopic study. Graefes Arch Clin Exp Ophthalmol (2007) 0.89
Corneal topographic changes after transconjunctival 23-gauge sutureless vitrectomy. Int Ophthalmol (2011) 0.88
Sympathetic ophthalmia after 23-gauge transconjunctival sutureless vitrectomy. Clin Ophthalmol (2010) 0.88
Conjunctival nevus-like lesions originating from a sclerotomy site after 23-gauge transconjunctival sutureless vitrectomy. Jpn J Ophthalmol (2010) 0.87
Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification for rhegmatogenous retinal detachment repair. Int J Ophthalmol (2015) 0.87
Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases. Graefes Arch Clin Exp Ophthalmol (2006) 0.86
Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes. Clin Ophthalmol (2014) 0.86
Efficacy and safety of active silicone oil removal through a 23-gauge transconjunctival cannula using an external vacuum pump. Int J Ophthalmol (2015) 0.85
Sutureless vitrectomy surgery. Ophthalmology (2003) 0.85
Comparison of surgically-induced astigmatism after combined phacoemulsification and 23-gauge vitrectomy: 2.2-mm vs. 2.75-mm cataract surgery. Korean J Ophthalmol (2014) 0.85
Intraoperative iatrogenic peripheral retinal break in 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge conventional vitrectomy. Graefes Arch Clin Exp Ophthalmol (2013) 0.84
Ultrasound biomicroscopy findings of 25 G Transconjuctival Sutureless (TSV) and conventional (20G) pars plana sclerotomy in the same patient. BMC Ophthalmol (2006) 0.84
A2e mediated phototoxic effects of endoilluminators. Br J Ophthalmol (2006) 0.84
Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment. Int J Ophthalmol (2012) 0.83
[Long-term results after pars plana vitrectomy with 25 gauge technique]. Ophthalmologe (2008) 0.83
Transconjunctival Sutureless 23-gauge Vitrectomy for Vitreoretinal Diseases: Outcome of 30 Consecutive Cases. Middle East Afr J Ophthalmol (2008) 0.81
Gentamicin-induced macular infarction in transconjunctival sutureless 25-gauge vitrectomy. Int Ophthalmol (2007) 0.81
Evaluation of microincision vitrectomy surgery using wide-viewing system for complications with ocular sarcoidosis. Medicine (Baltimore) (2015) 0.81
Preoperative factors predictive of postoperative decimal visual acuity ≥ 1.0 following surgical treatment for idiopathic epiretinal membrane. Clin Ophthalmol (2011) 0.81
Sutureless vitrectomy surgery. Ophthalmology (2003) 0.80
Outcomes of 23-gauge pars plana vitrectomy in vitreoretinal diseases. Clin Ophthalmol (2011) 0.80
Development of Microelectromechanical Systems (MEMS) forceps for intraocular surgery. Br J Ophthalmol (2005) 0.79
Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25-gauge and 20-gauge techniques. Jpn J Ophthalmol (2009) 0.79
Use of 25% sulfur hexafluoride gas mixture may minimize short-term postoperative hypotony in sutureless 25-gauge pars plana vitrectomy surgery. Clin Ophthalmol (2013) 0.78
Vitreoretinal fellow surgical outcome of small gauge pars plana vitrectomy for acute rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol (2011) 0.78
Comparison of efficacy and safety between transconjunctival 23-gauge and conventional 20-gauge vitrectomy systems in macular surgery. Korean J Ophthalmol (2012) 0.77
Minimally invasive vitreoretinal surgery: is sutureless vitrectomy the future of vitreoretinal surgery? J Ophthalmic Vis Res (2011) 0.77
Selective gene transfer to the retina using intravitreal ultrasound irradiation. J Ophthalmol (2012) 0.76
Differences between the combination of the 25-gauge vitrectomy with phacoemulsification versus 20-gauge vitrectomy and phacofragmentation. Clin Ophthalmol (2009) 0.76
Factors influencing self-sealing of sclerotomy performed under gas tamponade in 23-gauge transconjunctival sutureless vitrectomy. Clin Ophthalmol (2014) 0.75
A phacovitrectomy with a clear corneal incision for a full-thickness macular hole. Korean J Ophthalmol (2006) 0.75
In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography. J Ophthalmol (2013) 0.75
A review of developments in the management of retinal diseases. J R Soc Med (2006) 0.75
Sutureless virectomy surgery. Ophthalmology (2003) 0.75
Surgical outcomes of 23-gauge transconjunctival pars plana vitrectomy combined with lensectomy for glaucomatous eyes with extremely shallow anterior chamber and cataract. BMC Ophthalmol (2016) 0.75
Perioperative changes of the intraocular pressure during the treatment of epiretinal membrane by using 25- or 27-gauge sutureless vitrectomy without gas tamponade. Clin Ophthalmol (2017) 0.75
Comparison of microbiology and visual outcomes of patients undergoing small-gauge and 20-gauge vitrectomy for endophthalmitis. Clin Ophthalmol (2016) 0.75
Acute endophthalmitis following 23-gauge sutureless transconjunctival vitrectomy. Indian J Ophthalmol (2011) 0.75
Learning curve of sutureless transconjunctival 20-gauge vitrectomy. Clin Ophthalmol (2014) 0.75
Influence of silicone oil tamponade on self-sealing sclerotomy using 25-gauge transconjunctival sutureless vitrectomy: a retrospective comparative study. BMC Ophthalmol (2015) 0.75
Success Rates of Vitrectomy in Treatment of Rhegmatogenous Retinal Detachment. J Ophthalmol (2016) 0.75
Comparison between Limbal and Pars Plana Approaches Using Microincision Vitrectomy for Removal of Congenital Cataracts with Primary Intraocular Lens Implantation. J Ophthalmol (2016) 0.75
25th RCOphth Congress, President's Session paper: 25 years of progress in vitreoretinal surgery. Eye (Lond) (2014) 0.75
Corneal topographic changes and surgically induced astigmatism following combined phacoemulsification and 25-gauge vitrectomy. Int J Ophthalmol (2017) 0.75
Comparison of 25-gauge sutureless vitrectomy and 20-gauge vitrectomy in the treatment of posterior capsule opacification in pseudophakic children. Int J Ophthalmol (2015) 0.75
Vitreoretinal instruments: vitrectomy cutters, endoillumination and wide-angle viewing systems. Int J Retina Vitreous (2016) 0.75
25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature. Int J Ophthalmol (2014) 0.75
Cataract formation following vitreoretinal procedures. Clin Ophthalmol (2014) 0.75
Investigation of postoperative intraocular pressure in cases of silicone oil removal using 25-gauge transconjunctival sutureless vitrectomy with oblique incisions. Clin Ophthalmol (2015) 0.75
Non-vitrectomizing surgery for idiopathic macular pucker using a 25-gauge synergetics high-flow infusion with a 27-gauge light (Photon II, Synergetics USA, Inc.). Int Ophthalmol (2009) 0.75
Review of Small Gauge Vitrectomy: Progress and Innovations. J Ophthalmol (2017) 0.75
A new infusion sustainer that stabilizes perfusion during sutureless 25-gauge vitrectomy. Int Ophthalmol (2010) 0.75
Anatomical and Functional Results Following 23-Gauge Primary Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Superior versus Inferior Breaks. J Ophthalmol (2017) 0.75
[Three-dimensional visualization of sclerotomies with ultrasound biomicroscopy. Comparison of 20 and 23 gauge incisions on the porcine eyeball]. Ophthalmologe (2011) 0.75
25G compared with 20G vitrectomy under Resight non-contact wide-angle lenses for Terson syndrome. Exp Ther Med (2017) 0.75
Influences of 27-Gauge Vitrectomy on Corneal Topographic Conditions. J Ophthalmol (2017) 0.75
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology (2006) 9.01
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell (2007) 5.14
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology (2006) 4.48
PMN-PT single crystal, high-frequency ultrasonic needle transducers for pulsed-wave Doppler application. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 4.16
A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology (2002) 4.10
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology (2005) 2.85
The white dot syndromes. Am J Ophthalmol (2004) 2.28
Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant. Arch Ophthalmol (2009) 1.96
Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa. Am J Ophthalmol (2007) 1.88
Retinal prosthesis. Annu Rev Biomed Eng (2005) 1.84
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina (2007) 1.82
Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. Prog Brain Res (2009) 1.74
Retinal prostheses: current clinical results and future needs. Ophthalmology (2011) 1.70
In vitro electrical properties for iridium oxide versus titanium nitride stimulating electrodes. IEEE Trans Biomed Eng (2002) 1.63
Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology (2007) 1.62
Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology (2002) 1.59
High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal. Proc Natl Acad Sci U S A (2006) 1.56
Factors affecting perceptual thresholds in epiretinal prostheses. Invest Ophthalmol Vis Sci (2008) 1.55
Perceptual thresholds and electrode impedance in three retinal prosthesis subjects. IEEE Trans Neural Syst Rehabil Eng (2005) 1.52
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology (2010) 1.49
A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med (2014) 1.46
Retinal prosthesis for the blind. Surv Ophthalmol (2002) 1.43
Effect of oxygenated intraocular irrigation solutions on the electroretinogram after vitrectomy. Retina (2007) 1.43
Vitreous dynamics: vitreous flow analysis in 20-, 23-, and 25-gauge cutters. Retina (2008) 1.42
Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology (2002) 1.41
A novel method to oxygenate intraocular irrigation fluids with an in-line oxygenator. Retina (2007) 1.39
Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology (2002) 1.32
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. Arch Ophthalmol (2009) 1.32
Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci (2013) 1.30
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol (2004) 1.26
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. Cancer Cell (2011) 1.25
Predicting visual sensitivity in retinal prosthesis patients. Invest Ophthalmol Vis Sci (2008) 1.21
Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol (2003) 1.21
An in vitro model of a retinal prosthesis. IEEE Trans Biomed Eng (2008) 1.20
Visual and electrical evoked response recorded from subdural electrodes implanted above the visual cortex in normal dogs under two methods of anesthesia. J Neurosci Methods (2003) 1.18
In vitro and in vivo evaluation of ultrananocrystalline diamond for coating of implantable retinal microchips. J Biomed Mater Res B Appl Biomater (2006) 1.15
Performance analysis of new-generation vitreous cutters. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res (2012) 1.10
Visually guided performance of simple tasks using simulated prosthetic vision. Artif Organs (2003) 1.09
Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina (2004) 1.09
Brightness as a function of current amplitude in human retinal electrical stimulation. Invest Ophthalmol Vis Sci (2009) 1.07
Fluidics in a dual pneumatic ultra high-speed vitreous cutter system. Ophthalmologica (2012) 1.07
Measurements of attenuation coefficient for evaluating the hardness of a cataract lens by a high-frequency ultrasonic needle transducer. Phys Med Biol (2009) 1.06
Frequency and amplitude modulation have different effects on the percepts elicited by retinal stimulation. Invest Ophthalmol Vis Sci (2012) 1.03
Effects of intravitreal indocyanine green injection in rabbits. Retina (2004) 1.03
Imaging the response of the retina to electrical stimulation with genetically encoded calcium indicators. J Neurophysiol (2013) 1.03
Stem cell therapy for retinal disease. Curr Opin Ophthalmol (2012) 1.02
Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol (2004) 1.02
Long-term stimulation by active epiretinal implants in normal and RCD1 dogs. J Neural Eng (2005) 1.02
The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci (2007) 1.01
Evaluation of lens hardness in cataract surgery using high-frequency ultrasonic parameters in vitro. Ultrasound Med Biol (2007) 1.01
Virtual vitreoretinal surgical simulator as a training tool. Retina (2004) 1.01
Resolution of the epiretinal prosthesis is not limited by electrode size. IEEE Trans Neural Syst Rehabil Eng (2011) 1.01
Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion. Retina (2011) 1.00
Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol (2009) 1.00
Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells. Biomed Microdevices (2012) 1.00
Determining the acoustic properties of the lens using a high-frequency ultrasonic needle transducer. Ultrasound Med Biol (2007) 1.00
Facial recognition using simulated prosthetic pixelized vision. Invest Ophthalmol Vis Sci (2003) 0.99
Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol (2002) 0.99
Selective labeling of retinal ganglion cells with calcium indicators by retrograde loading in vitro. J Neurosci Methods (2009) 0.99
Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.98
Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes (2012) 0.98
The value of preoperative tests in the selection of blind patients for a permanent microelectronic implant. Trans Am Ophthalmol Soc (2003) 0.98
Comparison of electrical stimulation thresholds in normal and retinal degenerated mouse retina. Jpn J Ophthalmol (2004) 0.97
Advances in the development of visual prostheses. Curr Opin Ophthalmol (2003) 0.97
Electrical stimulation in normal and retinal degeneration (rd1) isolated mouse retina. Vision Res (2006) 0.97
Improvements after sheathotomy for branch retinal vein occlusion documented by optical coherence tomography and scanning laser ophthalmoscope. Ophthalmic Surg Lasers Imaging (2003) 0.97
Evaluation of a stereoscopic camera-based three-dimensional viewing workstation for ophthalmic surgery. Am J Ophthalmol (2007) 0.96
A passive MEMS drug delivery pump for treatment of ocular diseases. Biomed Microdevices (2009) 0.96
Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions. Diabetes (2010) 0.95
A new dual port cutter system for vitrectomy surgery. Retina (2010) 0.94
Paragraph text reading using a pixelized prosthetic vision simulator: parameter dependence and task learning in free-viewing conditions. Invest Ophthalmol Vis Sci (2006) 0.94
Electrical properties of retinal-electrode interface. J Neural Eng (2007) 0.94
Retinal prosthesis. IEEE Trans Biomed Eng (2014) 0.93
Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina (2004) 0.93
A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes. Malar J (2011) 0.92
Hyperspectral computed tomographic imaging spectroscopy of vascular oxygen gradients in the rabbit retina in vivo. PLoS One (2011) 0.91
Biofilm growth alters regulation of conjugation by a bacterial pheromone. Mol Microbiol (2011) 0.91
Retinal prostheses for the blind. Ann Acad Med Singapore (2006) 0.90
Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Can J Ophthalmol (2002) 0.90